Cargando…

Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis

BACKGROUND: Antimicrobial resistance of H. pylori can lead to treatment failure. Importantly, several studies have reported on heteroresistance, i.e. the presence of resistant and susceptible H. pylori populations in the same sample and/or a difference in the susceptibility patterns between biopsy s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kouhsari, Ebrahim, Sadeghifard, Nourkhoda, Khadiv, Arezoo, Sayadi, Hojjat, Amiriani, Taghi, Ghafourian, Sobhan, Valadbeigi, Hassan, Krutova, Marcela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123761/ https://www.ncbi.nlm.nih.gov/pubmed/35596211 http://dx.doi.org/10.1186/s12941-022-00509-3

Ejemplares similares

Persister cells as a possible cause of antibiotic therapy failure in Helicobacter pylori
por: Bahmaninejad, Parvin, et al.
Publicado: (2021)

The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis
por: Sholeh, Mohammad, et al.
Publicado: (2023)

Effect of ZnO nanoparticles on biofilm formation and gene expression of the toxin-antitoxin system in clinical isolates of Pseudomonas aeruginosa
por: Valadbeigi, Hassan, et al.
Publicado: (2023)

Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran
por: Khademi, Farzad, et al.
Publicado: (2013)

Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole
por: Tseng, Yen-Yu, et al.
Publicado: (2022)

Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis
por: Sholeh, Mohammad, et al.
Publicado: (2020)

Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
por: Kim, Jewel Ju Ea, et al.
Publicado: (2021)

First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin
por: Sue, Soichiro, et al.
Publicado: (2017)

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance
por: Adachi, Kazunori, et al.
Publicado: (2023)

Genotypic determination of resistance and heteroresistance to clarithromycin in Helicobacter pylori isolates from antrum and corpus of Colombian symptomatic patients
por: Arévalo-Jaimes, Betsy Verónica, et al.
Publicado: (2019)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Kashani, Negin, et al.
Publicado: (2018)

Is the mazEF toxin-antitoxin system responsible for vancomycin resistance in clinical isolates of Enterococcus faecalis?
por: Sadeghifard, Nourkhoda, et al.
Publicado: (2014)

Cross-Reaction between the Crude Hydatid Cyst Fluid Antigens of Human and Animals Origin in Response to Human IgG Class and Subclasses
por: Khosravi, Afra, et al.
Publicado: (2012)

Response to: Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Sue, Soichiro, et al.
Publicado: (2018)

Genetic basis for metronidazole and clarithromycin resistance in Helicobacter pylori strains isolated from patients with gastroduodenal disorders
por: Hashemi, Seyed Jalal, et al.
Publicado: (2019)

Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2018)

Comparative Study of Helicobacter Pylori Resistance to Clarithromycin and Metronidazole and Its Association with Epidemiological Factors in A Moroccan Population
por: Essaidi, Imane, et al.
Publicado: (2022)

Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori
por: Sue, Soichiro, et al.
Publicado: (2023)

Intraluminal Therapy for Helicobacter pylori Infection—Comparison of Medicament Containing Tetracycline, Metronidazole, and Bismuth versus Amoxicillin, Metronidazole, and Clarithromycin: A Randomized Controlled Study
por: Liu, Ting-Wen, et al.
Publicado: (2023)

Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
por: Sedighi, Mansour, et al.
Publicado: (2019)

High primary resistance to metronidazole and levofloxacin, and a moderate resistance to clarithromycin in Helicobacter pylori isolated from Karnataka patients
por: Shetty, Vignesh, et al.
Publicado: (2019)

Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter pylori Strains from Children in China
por: Zhang, Yanyi, et al.
Publicado: (2020)

Clarithromycin Versus Metronidazole in First-Line Helicobacter Pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis
por: Murata, Masaki, et al.
Publicado: (2020)

Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection
por: Mascellino, Maria Teresa, et al.
Publicado: (2017)

Characteristics of Helicobacter pylori Heteroresistance in Gastric Biopsies and Its Clinical Relevance
por: Wang, You-hua, et al.
Publicado: (2022)

Prevalence of OmpK35 and OmpK36 porin expression in beta-lactamase and non-betalactamase- producing Klebsiella pneumoniae
por: Shakib, Pegah, et al.
Publicado: (2012)

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)

Effect of Temperature on Metronidazole Resistance in Helicobacter pylori
por: Gong, Meiliang, et al.
Publicado: (2021)

Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains
por: Gong, Eun Jeong, et al.
Publicado: (2020)

Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori
por: Li, Xiao-Hua, et al.
Publicado: (2021)

Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains
por: Örsten, Serra, et al.
Publicado: (2023)

High Prevalence of AmpC β-Lactamases in Clinical Isolates of Escherichia coli in Ilam, Iran
por: Maleki, Abbas, et al.
Publicado: (2015)

Cloning, Expression, and Purification of Hyperthermophile α-Amylase from Pyrococcus woesei
por: Ghasemi, Amir, et al.
Publicado: (2015)

Traditional and Modern Cell Culture in Virus Diagnosis
por: Hematian, Ali, et al.
Publicado: (2016)

Association Between Toxin-Antitoxin Systems and Biofilm Formation
por: Karimi, Sajedeh, et al.
Publicado: (2014)

Epidemiological alteration in pathogens found in ground meat in Iran: unexpected predominance of vancomycin-resistant Enterococcus faecalis
por: Sadeghifard, Nourkhoda, et al.
Publicado: (2015)

Corrigendum to “Traditional and Modern Cell Culture in Virus Diagnosis”[Osong Public Health Res Perspect 2016;7(2):77–82]
por: Hematian, Ali, et al.
Publicado: (2020)

Helicobacter pylori and Its Antibiotic Heteroresistance: A Neglected Issue in Published Guidelines
por: Rizvanov, Albert A., et al.
Publicado: (2019)

Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study
por: Ben Mansour, Khansa, et al.
Publicado: (2010)

The mutation of the rdxA gene in metronidazole-resistant Helicobacter pylori clinical isolates
por: Mirzaei, Nasrin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0h323bqfec8ls8e52m0lvutc5o